Combining the Anti-Viral and Anti-Tumor CD8+T Cell Response Facilitates Immune Checkpoint Blockade Therapy and Oncolytic Virotherapy

被引：0
|
作者：
Sangsuwannukul, Thanich [1 ]
Kendall, Benjamin [1 ]
Webb, Mason J. [1 ]
Vloten, Jacob V. [1 ]
Evgin, Laura [1 ]
Tonne, Jason M. [1 ]
Thompson, Jill [1 ]
Metko, Muriel [1 ]
Moore, Madelyn [1 ]
Yerovi, Maria P. Chiriboga [1 ]
McNiven, Mark [1 ]
Singh, Monga Satdarshan Pal [1 ]
Borad, Mitesh [2 ]
Lewis, Roberts R. [1 ]
Vile, Richard G. [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Mayo Clin, Ctr Canc, Scottsdale, AZ USA
来源：
MOLECULAR THERAPY | 2024年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
230
引用
收藏
页码：123 / 124
页数：2
相关论文
共 50 条
  • [1] HDAC7 controls CD8+T cell dependent anti-viral and anti-tumor immunity
    Yerinde, Cansu
    Keye, Jacqueline
    Durlanik, Sibel
    Freise, Inka
    Schmidt, Franziska
    Schlickeiser, Stephan
    Obermayer, Benedikt
    Friedrich, Marie
    Wu, Hao
    Kunkel, Desiree
    Kuehl, Anja
    Bauer, Sebastian
    Thiel, Andreas
    Siegmund, Britta
    Glauben, Rainer
    Weidinger, Carl
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 45 - 45
  • [2] Evolution of anti-viral and anti-tumor immunity in tumors in response to oncolytic virus therapy
    Lyudovyk, Olga
    Burman, Bharat
    Ceglia, Nicholas
    Greenbaum, Benjamin
    Elhanati, Yuval
    Zamarin, Dmitriy
    CANCER RESEARCH, 2024, 84 (07)
  • [3] CD8+T cell precursor frequency determines the quality of the anti-tumor immune response
    Rizzuto, Gabrielle A.
    Merghoub, Taha
    Hirschhorn-Cymerman, Daniel
    Liu, Cailian
    Leskohin, Alexander M.
    Zhong, Hong
    Panageas, Katherine S.
    Perales, Miguel-Angel
    Altan-Bonnet, Gregoire
    Wolchok, Jedd D.
    Houghton, Alan N.
    JOURNAL OF IMMUNOLOGY, 2009, 182
  • [4] Targeting an anti-viral CD8+ T cell response to a growing tumor facilitates its rejection
    Waltraud Böhm
    Reinhold Schirmbeck
    J. Reimann
    Cancer Immunology, Immunotherapy, 1997, 44 : 230 - 238
  • [5] Targeting an anti-viral CD8(+) T cell response to a growing tumor facilitates its rejection
    Bohm, W
    Schirmbeck, R
    Reimann, J
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1997, 44 (04) : 230 - 238
  • [6] Defining the balance of anti-viral and anti-tumor T cell responses to oncolytic virus therapy using single cell approaches
    Burman, Bharat
    Ceglia, Nicholas
    Hirschhorn, Daniel
    Budhu, Sadna
    Mangarin, Levi
    Oseledchyk, Anton
    Bykov, Yonina
    McPherson, Andrew
    Shah, Sohrab
    Wolchok, Jedd
    Merghoub, Taha
    Zamarin, Dmitriy
    CANCER RESEARCH, 2022, 82 (12)
  • [7] ONCOLYTIC ADENOVIRUS THERAPY OF MALIGNANT GLIOMA IN IMMUNE COMPETENT MICE INDUCES ANTI-VIRAL AND ANTI-TUMOR IMMUNE RESPONSES
    Kleijn, A.
    Kloezeman, J. J.
    Treffers-Westerlaken, E. J.
    Leenstra, S.
    Dirven, C. M. F.
    Debets, R.
    Lamfers, M. M. L.
    NEURO-ONCOLOGY, 2012, 14 : 23 - 23
  • [8] The 16th International Oncolytic Virus Conference: Advancing oncolytic virotherapy by balancing anti-tumor and anti-viral immunity
    Stavrakaki, Eftychia
    Everts, Anne
    van den Hoogen, Bernadette G.
    Lamfers, Martine L. M.
    MOLECULAR THERAPY ONCOLOGY, 2025, 33 (01):
  • [9] HDAC7 controls CD8+ T cell dependent anti-viral and anti-tumor immunity
    Yerinde, C.
    Keye, J.
    Siegmund, B.
    Glauben, R.
    Weidinger, C.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 16 - 17
  • [10] Restoring CD8+T cell anti-HIV activity using combinatorial immune checkpoint blockade
    Jones, Amber D.
    Van Duyne, Rachel
    Khakhina, Svetlana
    Smith, Stephen M.
    Klase, Zachary A.
    JOURNAL OF IMMUNOLOGY, 2021, 206
12345